Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Dec;9(4):647-54.
doi: 10.1007/s10689-010-9368-z.

Regular surveillance for Li-Fraumeni Syndrome: advice, adherence and perceived benefits

C R M Lammens  1 , E M A Bleiker, N K Aaronson, A Wagner, R H Sijmons, M G E M Ausems, A H J T Vriends, M W G Ruijs, T A M van Os, L Spruijt, E B Gómez García, A Cats, T Nagtegaal, S Verhoef
Affiliations

Regular surveillance for Li-Fraumeni Syndrome: advice, adherence and perceived benefits

C R M Lammens et al. Fam Cancer. 2010 Dec.

Abstract

Li Fraumeni Syndrome (LFS) is a hereditary cancer syndrome characterized by a high risk of developing various types of cancer from birth through late adulthood. Clinical benefits of surveillance for LFS are limited. The aim of this study is to investigate which advice for regular surveillance, if any, is given to high risk LFS individuals, adherence to that advice, and any psychological gain or burden derived from surveillance. Fifty-five high risk individuals (proven carriers and those at 50% risk) from families with a p53 germline mutation were invited to participate, of whom 82% completed a self-report questionnaire assessing advice for regular surveillance, compliance, perceived benefits and barriers of screening and LFS-related distress (IES) and worries (CWS). In total, 71% of the high risk family members received advice to undergo regular surveillance for LFS. The majority (78%) reported adherence with the recommended advice. All high risk women aged 25 or older reported having been advised to undergo annual breast cancer surveillance (n = 11), of whom 64% (n = 7) in specific received advice to undergo a mammography. Seventy-eight percent of respondents indicated having received tailored surveillance advice based on family cancer history. The large majority of respondents believed in the value of surveillance to detect tumors at an early stage (90%) and reported that it gave them a sense of control (84%) and security (70%). Despite its limited clinical benefits, the majority of high risk LFS family are advised to undergo, and are adherent to, and report psychological benefit from, regular surveillance programs.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flowchart advice and adherence to regular surveillance for LFS
See this image and copyright information in PMC

References

    1. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990;250:1233–1238. doi: 10.1126/science.1978757. - DOI - PubMed
    1. Chompret A, Brugieres L, Ronsin M, et al. P53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer. 2000;82:1932–1937. doi: 10.1054/bjoc.2000.1167. - DOI - PMC - PubMed
    1. Hwang SJ, Lozano G, Amos CI, et al. Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. Am J Hum Genet. 2003;72:975–983. doi: 10.1086/374567. - DOI - PMC - PubMed
    1. Hisada M, Garber JE, Fung CY, et al. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst. 1998;90:606–611. doi: 10.1093/jnci/90.8.606. - DOI - PubMed
    1. Varley JM, Evans DG, Birch JM. Li-Fraumeni syndrome—a molecular and clinical review. Br J Cancer. 1997;76:1–14. - PMC - PubMed

Publication types